Financials
- Market Capitalization 1.84 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-16.21
市销率
396.94
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2058 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.79 USD | +3.43% | +3.48% | +9.36% | +28.97% | 1.86 B USD | ||
| 2060 | INBX Inhibrx Biosciences, Inc. - Common Stock | 124.32 USD | -0.27% | -0.81% | +51.87% | +54.28% | 1.83 B USD | ||
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.50% | -3.15% | +11.55% | -28.09% | 1.81 B USD | ||
| 2084 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.76 USD | +0.55% | -3.26% | +20.49% | -7.00% | 1.79 B USD |